Compras de personas con información privilegiada de los 6 últimos meses | Acciones | Trans |
---|---|---|
Compras | 0 | 0 |
Ventas | N/A | 0 |
Cuotas netas adquiridas (vendidas) | 0 | 0 |
Acciones de persona con información privilegiada totales | 2,72M | N/A |
% de acciones netas adquiridas (vendidas) | N/A | N/A |
Compras institucionales netas del trimestre anterior al último trimestre | Acciones |
---|---|
Cuotas netas adquiridas (vendidas) | N/A |
% de cambio en la posesión de acciones institucionales | N/A |
Persona con información privilegiada | Transacción | Tipo | Valor | Fecha | Acciones |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 2.21 per share. | Indirecto | 4.095.130 | 06 ene 2023 | 1.853.000 |
SEIDEL-DUGAN CYNTHIA PH.D. | Conversion of Exercise of derivative security at price 1.56 - 4.77 per share. | Directo | 111.838 | 12 ene 2022 | 39.731 |
LEONARD REID | Conversion of Exercise of derivative security at price 1.56 per share. | Directo | 21.999 | 30 dic 2021 | 14.102 |
LEONARD REID | Sale at price 13.39 - 13.97 per share. | Indirecto | 40.242 | 15 dic 2021 | 3.000 |
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 12.75 - 13.37 per share. | Indirecto | 4.129.398 | 16 jun 2021 | 323.298 |
EVNIN LUKE BASIL | Purchase at price 16.00 per share. | Indirecto | 2.412.784 | 04 may 2021 | 150.799 |
EVNIN LUKE BASIL | Indirecto | 04 may 2021 | 3.671.965 | ||
HBM HEALTHCARE INVESTMENTS CAYMAN LTD | Directo | 04 may 2021 | 625.995 | ||
GADICKE ANSBERT S. | Purchase at price 16.00 per share. | Indirecto | 3.920.000 | 04 may 2021 | 245.000 |
GADICKE ANSBERT S. | Indirecto | 04 may 2021 | 5.965.775 | ||
UPMC | Directo | 04 may 2021 | 1.097.756 | ||
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 16.00 per share. | Indirecto | 27.440.000 | 04 may 2021 | 1.715.000 |
RA CAPITAL MANAGEMENT, L.P. | Indirecto | 04 may 2021 | 2.253.583 | ||
FLYNN JAMES E | Purchase at price 16.00 per share. | Indirecto | 12.800.000 | 04 may 2021 | 800.000 |
FLYNN JAMES E | Indirecto | 04 may 2021 | 1.752.787 | ||
MPM BIOVENTURES 2014,L.P. | Purchase at price 16.00 per share. | Indirecto | 2.012.144 | 04 may 2021 | 125.759 |
MPM BIOVENTURES 2014,L.P. | Indirecto | 04 may 2021 | 3.062.239 | ||
LAZARUS ALON | Purchase at price 16.00 per share. | Indirecto | 6.400.000 | 04 may 2021 | 400.000 |
LAZARUS ALON | Indirecto | 04 may 2021 | 1.646.634 | ||
ASANUMA SAKAE | Purchase at price 16.00 per share. | Indirecto | 5.000.000 | 04 may 2021 | 312.500 |
ASANUMA SAKAE | Indirecto | 04 may 2021 | 1.756.409 | ||
ARKIN BIO VENTURES 2, LP. | Purchase at price 16.00 per share. | Indirecto | 6.400.000 | 04 may 2021 | 400.000 |
ARKIN BIO VENTURES 2, LP. | Indirecto | 04 may 2021 | 1.646.634 | ||
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Purchase at price 16.00 per share. | Indirecto | 7.600.000 | 04 may 2021 | 475.000 |
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Indirecto | 04 may 2021 | 312.997 | ||
TAIHO VENTURES, LLC | Purchase at price 16.00 per share. | Directo | 5.000.000 | 04 may 2021 | 312.500 |
TAIHO VENTURES, LLC | Directo | 04 may 2021 | 1.756.409 | ||
LONGWOOD FUND III GP, LLC | Purchase at price 16.00 per share. | Indirecto | 4.000.000 | 04 may 2021 | 250.000 |
LONGWOOD FUND III GP, LLC | Indirecto | 04 may 2021 | 1.427.082 |